Transcripts of neurokinin B and neurokinin 3 receptor in superovulated rat ovaries and increased number of corpora lutea as a non-specific effect of intraperitoneal agonist application

Regulatory Peptides

Volumn 122, Issue 2, 2004, Pages 131-137

  Löffler, Sabine ^a   Schulz, Anett ^a   Brylla, Elke ^a   Nieber, Karen ^a   Spanel Borowski, Katharina ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Corpus luteum; Neurokinin 3 receptor; Neurokinin B; Ovary; Ovulation

Indexed keywords

CHORIONIC GONADOTROPIN; MESSENGER RNA; N [ALPHA (METHOXYCARBONYL)BENZYL] 2 PHENYL 4 QUINOLINECARBOXAMIDE; NEUROKININ 3 RECEPTOR; NEUROKININ 3 RECEPTOR AGONIST; NEUROKININ B; NEUROKININ B DERIVATIVE; NEUROKININ B[7 PROLINE]; PROTEINASE INHIBITOR; SODIUM CHLORIDE; TACHYKININ; TACHYKININ RECEPTOR ANTAGONIST; THIORPHAN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CORPUS LUTEUM; ESTRUS CYCLE; FEMALE; GRANULOCYTE; GREATER OMENTUM; INFLAMMATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY; OVARY FOLLICLE DEVELOPMENT; OVULATION; PERITONEUM; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PUBERTY; RAT; RETROPERITONEUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STIMULATION; VALIDATION PROCESS;

ANIMALS; FEMALE; GONADOTROPINS, EQUINE; INFLAMMATION; INJECTIONS, INTRAPERITONEAL; NEUROKININ B; OVARY; RATS; RATS, WISTAR; RECEPTORS, NEUROKININ-3; RNA, MESSENGER; SUPEROVULATION; TRANSCRIPTION, GENETIC;

EID: 4544284892     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2004.06.009     Document Type: Article

References (37)

1. Patacchini R., Maggi C.A. Tachykinin receptors and receptor subtypes. Arch. Int. Pharmacodyn. Ther. 329:1995;161-184
2. Severini C., Improta G., Falconieri-Erspamer G., Salvadori S., Erspamer V. The tachykinin peptide family. Pharmacol. Rev. 54:2002;285-322
3. Cintado C.G., Pinto F.M., Devillier P., Merida A., Candenas M.L. Increase in neurokinin B expression and in tachykinin NK(3) receptor-mediated response and expression in the rat uterus with age. J. Pharmacol. Exp. Ther. 299:2001;934-938
4. Page N.M., Woods R.J., Gardiner S.M., Lomthaisong K., Gladwell R.T., Butlin D.J., et al. Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia. Nature. 405:2000;797-800
5. Page N.M., Woods R.J., Lowry P.J. A regulatory role for neurokinin B in placental physiology and pre-eclampsia. Regul. Pept. 98:2001;97-104
6. Majewski M., Sienkiewicz W., Kaleczyc J., Mayer B., Czaja K., Lakomy M. The distribution and co-localization of immunoreactivity to nitric oxide synthase, vasoactive intestinal polypeptide and substance P within nerve fibres supplying bovine and porcine female genital organs. Cell. Tissue Res. 281:1995;445-464
7. Papka R.E., Thompson B.D., Schmidt H.H. Identification of uterine-related sympathetic neurons in the rat inferior mesenteric ganglion: neurotransmitter content and afferent input. J. Auton. Nerv. Syst. 59:1996;51-59
8. Pinto F.M., Cintado C.G., Devillier P., Candenas M.L. Expression of preprotachykinin-B, the gene that encodes neurokinin B, in the rat uterus. Eur. J. Pharmacol. 425:2001;R1-R2
9. Pintado C.O., Pinto F.M., Pennefather J.N., Hidalgo A., Baamonde A., Sanchez T., et al. A role for tachykinins in female mouse and rat reproductive function. Biol. Reprod. 69:2003;940-946
10. Satake H., Kawada T., Nomoto K., Minakata H. Insight into tachykinin-related peptides, their receptors, and invertebrate tachykinins: a review. Zool. Sci. 20:2003;533-549
11. Hamlin G.P., Williams M.J., Nimmo A.J., Crane L.H. Hormonal variation of rat uterine contractile responsiveness to selective neurokinin receptor agonists. Biol. Reprod. 62:2000;1661-1666
12. Patak E.N., Pennefather J.N., Story M.E. Effects of tachykinins on uterine smooth muscle. Clin. Exp. Pharmacol. Physiol. 27:2000;922-927
13. Crane L.H., Williams M.J., Nimmo A.J., Hamlin G.P. Estrogen-dependent regulation of neurokinin 3 receptor-mediated uterine contractility in the rat. Biol. Reprod. 67:2002;1480-1487
14. Wareing M., Bhatti H., O'hara M., Kenny L., Warren A.Y., Taggart M.J., et al. Vasoactive effects of neurokinin B on human blood vessels. Am. J. Obstet. Gynecol. 188:2003;196-202
15. Hökfelt T., Pernow B., Wahren J. Substance P: a pioneer amongst neuropeptides. J. Intern. Med. 249:2001;27-40
16. Debeljuk L. Tachykinins in the normal and gonadotropin-stimulated ovary of the mouse. Peptides. 24:2003;1445-1448
17. Miyamoto A., Bruckmann A., von Lutzow H., Schams D. Multiple effects of Y neuropeptide, substance P and vasoactive intestinal polypeptide on progesterone and oxytocin release from bovine corpus luteum in vitro. J. Endocrinol. 138:1993;451-458
18. Kerdelhue B., Williams R.F., Lenoir V., Fardin V., Kolm P., Hodgen G.D., et al. Variations in plasma levels of substance P and effects of a specific substance P antagonist of the NK(1) receptor on preovulatory LH and FSH surges and progesterone secretion in the cycling cynomolgus monkey. Neuroendocrinology. 71:2000;228-236
19. Reibiger I., Aust G., Tscheudschilsuren G., Beyer R., Gebhardt C., Spanel-Borowski K. The expression of substance P and its neurokinin-1 receptor mRNA in the bovine corpus luteum of early developmental stage. Neurosci. Lett. 299:2001;49-52
20. Löffler S., Schulz A., Hunt S.P., Spanel-Borowski K. Increased formation of corpora lutea in neurokinin 1-receptor deficient mice. Mol. Reprod. Dev. 2004;. [in press]
21. Lederer L.D. On the selective enzyme-cytochemical demonstration of neutrophilic myeloid cells and tissue mast cells in paraffin sections. Klin. Wochenschr. 42:1964;553
22. Bogomoletz W. Avantages de la coloration par le rouge sirius de l'amyloide et des eosinophiles. Arch. Anat. Cytol. Pathol. 28:1980;252-253
23. Styszynski A., Podkowka R., Wieczorowska-Tobis K., Kwiatkowska B., Ksiazek K., Breborowicz A., et al. Glucose suppresses peritoneal inflammatory reactions and mesothelial hyperplasia caused by intraperitoneal saline infusion. Adv. Perit. Dial. 18:2002;21-25
24. Dees W.L., Ahmed C.E., Ojeda S.R. Substance P- and vasoactive intestinal peptide-containing fibers reach the ovary by independent routes. Endocrinology. 119:1986;638-641
25. Candenas M.L., Magraner J., Armesto C.P., Anselmi E., Nieto P.M., Martin J.D., et al. Changes in the expression of tachykinin receptors in the rat uterus during the course of pregnancy. Biol. Reprod. 65:2001;538-543
26. Schmidt C., Lobos E., Spanel-Borowski K. Pregnancy-induced changes in substance P and neurokinin 1 receptor (NK1-R) expression in the rat uterus. Reproduction. 126:2003;451-458
27. Ho W.Z., Lai J.P., Zhu X.H., Uvaydova M., Douglas S.D. Human monocytes and macrophages express substance P and neurokinin-1 receptor. J. Immunol. 159:1997;5654-5660
28. Stones R.W., Loesch A., Beard R.W., Burnstock G. Substance P: endothelial localization and pharmacology in the human ovarian vein. Obstet. Gynecol. 85:1995;273-278
29. Chiwakata C., Brackmann B., Hunt N., Davidoff M., Schulze W., Ivell R. Tachykinin (substance-P) gene expression in Leydig cells of the human and mouse testis. Endocrinology. 128:1991;2441-2448
30. Wallace J.L., McCafferty D.M., Sharkey K.A. Lack of beneficial effect of a tachykinin receptor antagonist in experimental colitis. Regul. Pept. 73:1998;95-101
31. Evangelista S., Maggi M., Renzetti A.R. Down-regulation of substance P receptors during colitis induced by trinitrobenzene sulfonic acid in rats. Neuropeptides. 30:1996;425-428
32. Patacchini R., Maggi C.A. Peripheral tachykinin receptors as targets for new drugs. Eur. J. Pharmacol. 429:2001;13-21
33. Bukulmez O., Arici A. Leukocytes in ovarian function. Hum. Reprod. Updat. 6:2000;1-15
34. Brännström M., Enskog A. Leukocyte networks and ovulation. J. Reprod. Immunol. 57:2002;47-60
35. Arbeitsgemeinschaft der Tierschutzbeauftragten in Baden-Württemberg: Empfohlene maximale Injektionsvolumina bei Versuchstieren. Tierschutzbeauftragte. 3:1997;204
36. Pinto F.M., Armesto C.P., Magraner J., Trujillo M., Martin J.D., Candenas M.L. Tachykinin receptor and neutral endopeptidase gene expression in the rat uterus: characterization and regulation in response to ovarian steroid treatment. Endocrinology. 140:1999;2526-2532
37. Patak E., Candenas M.L., Pennefather J.N., Ziccone S., Lilley A., Martin J.D., et al. Tachykinins and tachykinin receptors in human uterus. Br. J. Pharmacol. 139:2003;523-532